Unpredictability of Deception in Compliance With Physician-Prescribed Bronchodilator Inhaler Use in a Clinical Trial
Authors:
- Michael S. SimmonsMSMichael S. Simmons
- Mitchell A. NidesMNMitchell A. Nides
- Cynthia S. RandCRCynthia S. Rand
- Robert A. WiseRWRobert A. Wise
- Donald P. TashkinDTDonald P. Tashkin
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Noncompliance and treatment failure in children with asthmaJournal of Allergy and Clinical Immunology, 1996
- Trends in Compliance With Bronchodilator Inhaler Use Between Follow-up Visits in a Clinical TrialChest, 1996
- Therapeutic implications of drug 'holidays'European Heart Journal, 1996
- Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1JAMA, 1994
- Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring.Journal of Clinical Oncology, 1993
- Metered-Dose Inhaler Adherence in a Clinical TrialAmerican Review of Respiratory Disease, 1992
- Measuring compliance with inhaled medication in asthma.Archives of Disease in Childhood, 1992
- The natural history of medication compliance in a drug trial: Limitations of pill countsClinical Pharmacology & Therapeutics, 1989
- How Often Is Medication Taken as Prescribed?JAMA, 1989
- Compliance of patients with asthma with an experimental aerosolized medication: Implications for controlled clinical trialsJournal of Allergy and Clinical Immunology, 1986